Citadel Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $390M | Buy |
5,428,043
+1,826,690
| +51% | +$141M | 0.06% | 233 |
|
|
2025
Q4 | $286M | Buy |
3,601,353
+384,176
| +12% | +$30.3M | 0.04% | 360 |
|
|
2025
Q3 | $243M | Sell |
3,217,177
-4,959,383
| -61% | -$340M | 0.04% | 397 |
|
|
2025
Q2 | $564M | Buy |
8,176,560
+1,916,310
| +31% | +$126M | 0.1% | 145 |
|
|
2025
Q1 | $424M | Sell |
6,260,250
-106,195
| -2% | -$6.35M | 0.08% | 165 |
|
|
2024
Q4 | $286M | Buy |
6,366,445
+4,202,234
| +194% | +$236M | 0.05% | 278 |
|
|
2024
Q3 | $136M | Buy |
2,164,211
+2,020,097
| +1,402% | +$118M | 0.03% | 529 |
|
|
2024
Q2 | $8.51M | Buy |
144,114
+9,919
| +7% | +$620K | ﹤0.01% | 2987 |
|
|
2024
Q1 | $10.7M | Sell |
134,195
-1,514,175
| -92% | -$116M | ﹤0.01% | 2864 |
|
|
2023
Q4 | $130M | Buy |
1,648,370
+472,455
| +40% | +$33.6M | 0.03% | 539 |
|
|
2023
Q3 | $82.1M | Buy |
1,175,915
+286,249
| +32% | +$20.3M | 0.02% | 732 |
|
|
2023
Q2 | $61.5M | Sell |
889,666
-437,927
| -33% | -$31.2M | 0.01% | 900 |
|
|
2023
Q1 | $98.7M | Buy |
1,327,593
+522,836
| +65% | +$43.8M | 0.02% | 618 |
|
|
2022
Q4 | $75M | Sell |
804,757
-649,943
| -45% | -$62.7M | 0.02% | 819 |
|
|
2022
Q3 | $139M | Buy |
1,454,700
+429,938
| +42% | +$42.6M | 0.03% | 440 |
|
|
2022
Q2 | $95M | Buy |
1,024,762
+933,954
| +1,028% | +$91.2M | 0.02% | 603 |
|
|
2022
Q1 | $9.19M | Sell |
90,808
-1,109,469
| -92% | -$117M | ﹤0.01% | 3082 |
|
|
2021
Q4 | $124M | Buy |
1,200,277
+1,080,656
| +903% | +$99.9M | 0.03% | 541 |
|
|
2021
Q3 | $10.2M | Sell |
119,621
-755,353
| -86% | -$63.3M | ﹤0.01% | 3049 |
|
|
2021
Q2 | $73M | Sell |
874,974
-320,708
| -27% | -$26.3M | 0.02% | 860 |
|
|
2021
Q1 | $90M | Buy |
1,195,682
+614,106
| +106% | +$44.7M | 0.02% | 638 |
|
|
2020
Q4 | $39.7M | Sell |
581,576
-330,737
| -36% | -$21.5M | 0.01% | 1144 |
|
|
2020
Q3 | $53.3M | Sell |
912,313
-339,840
| -27% | -$21.1M | 0.02% | 819 |
|
|
2020
Q2 | $81.4M | Buy |
1,252,153
+777,572
| +164% | +$49M | 0.03% | 508 |
|
|
2020
Q1 | $28.2M | Sell |
474,581
-747,526
| -61% | -$49.9M | 0.01% | 969 |
|
|
2019
Q4 | $90.8M | Sell |
1,222,107
-1,826,925
| -60% | -$128M | 0.04% | 441 |
|
|
2019
Q3 | $192M | Buy |
3,049,032
+635,777
| +26% | +$37.7M | 0.09% | 166 |
|
|
2019
Q2 | $131M | Sell |
2,413,255
-76,919
| -3% | -$4.14M | 0.06% | 282 |
|
|
2019
Q1 | $134M | Buy |
2,490,174
+1,363,920
| +121% | +$84.2M | 0.07% | 254 |
|
|
2018
Q4 | $73.8M | Sell |
1,126,254
-544,403
| -33% | -$40.6M | 0.04% | 445 |
|
|
2018
Q3 | $132M | Buy |
1,670,657
+1,277,176
| +325% | +$91.3M | 0.06% | 316 |
|
|
2018
Q2 | $25.3M | Sell |
393,481
-426,842
| -52% | -$28.1M | 0.01% | 1127 |
|
|
2018
Q1 | $51M | Sell |
820,323
-2,309,739
| -74% | -$166M | 0.03% | 586 |
|
|
2017
Q4 | $227M | Buy |
3,130,062
+2,794,481
| +833% | +$203M | 0.14% | 116 |
|
|
2017
Q3 | $27.3M | Buy |
335,581
+285,017
| +564% | +$22.5M | 0.02% | 888 |
|
|
2017
Q2 | $4.07M | Buy |
50,564
+4,542
| +10% | +$359K | ﹤0.01% | 2342 |
|
|
2017
Q1 | $3.61M | Sell |
46,022
-318,372
| -87% | -$25.4M | ﹤0.01% | 2384 |
|
|
2016
Q4 | $28.8M | Sell |
364,394
-268,444
| -42% | -$21.7M | 0.03% | 639 |
|
|
2016
Q3 | $56.3M | Buy |
632,838
+4,156
| +0.7% | +$392K | 0.06% | 335 |
|
|
2016
Q2 | $60.2M | Buy |
628,682
+608,682
| +3,043% | +$60.7M | 0.07% | 266 |
|
|
2016
Q1 | $2.08M | Sell |
20,000
-623,632
| -97% | -$60.6M | ﹤0.01% | 2603 |
|
|
2015
Q4 | $62.9M | Sell |
643,632
-22,684
| -3% | -$2.22M | 0.07% | 307 |
|
|
2015
Q3 | $64.3M | Buy |
666,316
+643,937
| +2,877% | +$67.7M | 0.06% | 332 |
|
|
2015
Q2 | $2.35M | Sell |
22,379
-375,916
| -94% | -$38.4M | ﹤0.01% | 2883 |
|
|
2015
Q1 | $41.1M | Sell |
398,295
-1,484,184
| -79% | -$150M | 0.04% | 570 |
|
|
2014
Q4 | $181M | Buy |
1,882,479
+551,190
| +41% | +$48.6M | 0.18% | 80 |
|
|
2014
Q3 | $106M | Buy |
1,331,289
+1,058,114
| +387% | +$83.4M | 0.11% | 177 |
|
|
2014
Q2 | $20.6M | Sell |
273,175
-34,213
| -11% | -$2.59M | 0.02% | 793 |
|
|
2014
Q1 | $23M | Buy |
307,388
+23,221
| +8% | +$1.64M | 0.03% | 748 |
|
|
2013
Q4 | $20.3M | Buy |
284,167
+156,551
| +123% | +$10.1M | 0.03% | 790 |
|
|
2013
Q3 | $7.24M | Sell |
127,616
-837,498
| -87% | -$49.9M | 0.01% | 1305 |
|
|
2013
Q2 | $55.2M | Buy |
+965,114
| New | +$55.9M | 0.09% | 234 |
|
Other funds holding CVS
VCM
VPM
Citadel Advisors's CVS Position: Q1 2026 in Review
Citadel Advisors increased its CVS Health (CVS) stake by 51% in Q1 2026, buying an estimated $141M and bringing the position to 5,428,043 shares worth $390M. The position accounts for 0.06% of the portfolio, ranked #233.
Citadel Advisors first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $564M in Q2 2025. 1,874 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Citadel Advisors held 5,428,043 shares of CVS Health worth $390M as of Q1 2026.
- Citadel Advisors bought 1,826,690 CVS Health shares in Q1 2026, an estimated $141M.
- CVS Health made up 0.06% of Citadel Advisors's portfolio in Q1 2026, its #233 holding.
- Citadel Advisors first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Citadel Advisors's CVS Health position peaked at $564M in Q2 2025.
- 1,874 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.